Heterogeneity of response and survival in diffuse histiocytic lymphoma after BACOP therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone). (Q45051134)
Jump to navigation
Jump to search
scientific article published in April 1985
Language | Label | Description | Also known as |
---|---|---|---|
English | Heterogeneity of response and survival in diffuse histiocytic lymphoma after BACOP therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone). |
scientific article published in April 1985 |
Statements
1 reference
Heterogeneity of response and survival in diffuse histiocytic lymphoma after BACOP therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone). (English)
1 reference
Levine AM
1 reference
Goldstein M
1 reference
Meyer PR
1 reference
Forman SJ
1 reference
Parker JW
1 reference
Paganini-Hill A
1 reference
Lukes RJ
1 reference
Feinstein DI
1 reference
1 April 1985
1 reference
1 reference
3
1 reference
2
1 reference
87-98
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference